Pharma IQ Members


Biologics includes a wide range of medicinal products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins created by biological processes. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources like human, animal, or microorganism and may be produced by biotechnology methods and other technologies.

Improving the Security, Quality & Compliance of your Biologic Operation

In the coming years, biologics are expected to make up a greater proportion of revenue growth for pharmaceutical companies, with some figures placing it as high as 60 per cent.  The US Food and Drug Administration last year approved a total of 24...

Contributor: Pharma IQ
Mon, 02/20/2012
Growing Number of Biologics Expand and Challenge Transportation Services

The market for biologics is expected to see significant growth in the foreseeable future. This follows a strong two years which saw the category contribute 17 percent of global pharmaceutical sales in the 12 months leading to March 2009,...

Contributor: Pharma IQ
Wed, 01/26/2011
Pharma IQ

Pharma IQ chats with Eileen Edmonson, Pipeline and Hazardous Materials Safety Administration, U.S. Department of Transportation, about navigating the U.S. Department of Transportation’s regulations for biologics and biological agents.

Contributor: Pharma IQ
Tue, 04/20/2010